YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Intuitive Surgical's ISRG technology strategy is becoming increasingly important as competition in robotic surgery intensifies. The company is using artificial intelligence, software and data-driven capabilities to make its da Vinci ecosys…
Stereotaxis, Inc. University of Szeged installed Hungary's first Robotic Magnetic Navigation system in July Over 70 patients with all forms of arrhythmia treated robotically to date, a record pace of use globally Robotics enabled successfu…
Image source: The Motley Fool. DATE Tuesday, Aug. 11, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer - David Fischel Chief Financial Officer - Kimberly Peery Full Conference Call Transcript Operator: Good after…
Intuitive Surgical ISRG has faced a moderation in U.S. procedure growth during the first half of 2026, but management's commentary suggests the slowdown is more likely a temporary demand-timing issue than evidence of a structural deteriora…
Stereotaxis, Inc. Q2 2026 Earnings Call Summary - Moby Strategic Transformation and Commercial Inflection Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our…
Earnings Call Insights: Stereotaxis (STXS) Q2 2026 MANAGEMENT VIEW * "We just celebrated a particularly milestone-rich period with regulatory approvals for a new robot, both therapeutic and diagnostic catheters, and a digital surgery syste…
Major earnings expected before the bell on Wednesday include: * Nebius Group N.V. (NBIS [https://seekingalpha.com/symbol/NBIS]) * Tencent Holdings Limited (TCEHY [https://seekingalpha.com/symbol/TCEHY]) * Brinker International (EAT [https:…
Teleflex (TFX) came out with quarterly earnings of $1.76 per share, beating the Zacks Consensus Estimate of $1.28 per share. This compares to earnings of $3.73 per share a year ago. These figures are adjusted for non-recurring items. This…
Mobia Medical, Inc. AUSTIN, Texas, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today…
Integer (ITGR) shares ended the last trading session 20.2% higher at $121.21. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 6% gain over the pa…
Veracyte (VCYT) came out with quarterly earnings of $0.54 per share, beating the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.44 per share a year ago. These figures are adjusted for non-recurring items. This…
First Robotic Magnetic Navigation system installed in HungaryUniversity of Szeged, led by Cardiology Chief Dr. Szili-Torok, expected to treat hundreds of patients annually with all forms of cardiac arrhythmia using precision of robotics ST…
Intuitive Surgical ISRG is navigating an increasingly competitive robotic surgery landscape as domestic Chinese manufacturers, European innovators and large global medtech companies expand their presence. Management acknowledged persistent…
Intuitive Surgical ISRG is set to release second-quarter results on July 16. The Zacks Consensus Estimate for sales is pegged at $2.81 billion, indicating year-over-year growth of 15%, and the same for earnings per share (EPS) implies an i…
(RTTNews) - Stereotaxis Inc. (STXS), a surgical robotics company, on Thursday announced the acquisition of Robocath, an established robotics company for interventions in cardiology and neurointerventions. The companies plan to pool resourc…
Given its significant hedge fund backing and attractive upside potential, Stereotaxis, Inc. (NYSEAMERICAN:STXS) is one of the most promising robotics stocks.Citizens Sees Compelling Razor/Razor Blade Ecosystem As A Driver Of Sustainable Gr…
Intuitive Surgical ISRG delivered a strong capital performance in the first quarter of 2026. The company placed 431 da Vinci systems during the quarter, up 17% year over year, signaling continued robust demand for robotic-assisted surgery.…
Intuitive Surgical’s ISRG Ion platform is increasingly emerging as a potentially meaningful growth engine, supported by accelerating procedural adoption and growing clinical validation in lung cancer care. In the first quarter of 2026, Ion…
Trading with an implied upside of 124.7% and an RSI of 39.6, Stereotaxis, Inc. (NYSEAMERICAN:STXS) has emerged as a notable oversold play in the AI sector.Analysts See 124.7% Upside In Stereotaxis (STXS); Find Out Why However, more recentl…
Earnings Call Insights: Stereotaxis, Inc. (STXS) Q1 2026 MANAGEMENT VIEW * "Stereotaxis has had an amazing start to this year" and management framed Q1 as a period where "our reported quarterly numbers don't yet reflect it," while citing "…
Proprietary robotically-navigated MAGiC catheter received U.S. FDA approval in January and is now being utilized at multiple sites across the United States as well as EuropeSynchrony digital operating room system received U.S. FDA clearanc…
Integra LifeSciences (IART) came out with quarterly earnings of $0.54 per share, beating the Zacks Consensus Estimate of $0.41 per share. This compares to earnings of $0.41 per share a year ago. These figures are adjusted for non-recurring…
Stereotaxis STXS has announced the first successful U.S. procedures using its MAGiC robotic magnetic ablation catheter, following recent approval from the FDA. The milestone highlights the company’s progress in advancing minimally invasive…
ST. LOUIS, April 21, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2026…
Stereotaxis STXS has announced the expansion of its footprint in robotic endovascular surgery with a definitive agreement to acquire Robocath, a developer of robotic solutions for interventional cardiology and neurointerventions. The trans…
US medical technology company Stereotaxis has agreed to acquire smart robotic solutions developer Robocath in a deal worth up to $45m. The acquisition is intended to strengthen Stereotaxis’ position in the sector by expanding its platform…
ST. LOUIS and ROUEN, France, April 15, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has entered into a definit…
Stereotaxis STXS recently announced that the FDA granted 510(k) clearance for its Synchrony system, a next-generation platform aimed at modernizing interventional cath labs. The Synchrony system is designed to streamline cath lab operation…
(RTTNews) - Stereotaxis (STXS) said it has received FDA 510(k) clearance for the Synchrony system. Synchrony is designed to digitize and modernize the interventional cath lab. Synchrony's 55 4K ultra-high-definition display consolidates th…
Intuitive Surgical ISRG is facing intensifying competitive and policy-driven pressures in China, raising questions around the durability of its positioning in one of its key international growth markets. Management highlighted that provinc…
Key Points DAFNA Capital Management sold 222,847 SNDX shares in the fourth quarter for an estimated roughly $4 million. Meanwhile, the quarter-end position value decreased by $1.87 million, reflecting both trading and price movements. The…
Key Points DAFNA Capital Management sold 265,456 AXGN shares in the fourth quarter, with an estimated transaction value of $6.53 million based on quarterly average prices. Meanwhile, the quarter-end position value decreased by $2.36 millio…
Key Points DAFNA Capital Management bought 720,000 shares of Biohaven in the fourth quarter; the estimated trade size was $8.92 million, based on average prices in the fourth quarter of 2025. Meanwhile, the quarter-end value of the positio…
Key Points DAFNA Capital Management LLC sold 34,405 shares of iShares Biotechnology ETF (IBB) Quarter-end position value decreased by $3.31 million, reflecting both trading and stock price effects Trade represented a 1.3% reduction of 13F…
What happened According to an SEC filing dated February 17, 2026, DAFNA Capital Management LLC reduced its stake in iShares Biotechnology ETF(NASDAQ:IBB) by 34,405 shares during the fourth quarter of 2025. The fund’s quarter-end IBB positi…
Earnings Call Insights: Stereotaxis (STXS) Q4 2025 MANAGEMENT VIEW * CEO David Fischel described 2025 as a year of “tremendous progress,” emphasizing technological and commercial advancements despite ongoing challenges. Fischel highlighted…